Product Name: JNJ-17029259
Description: JNJ-17029259 is an orally selective, nanomolar inhibitors of the vascular endothelial growth factor receptor-2 (VEGF-R2). JNJ-17029259 blocks VEGF-stimulated mitogen-activated protein kinase signaling, proliferation/migration, and VEGF-R2 phosphorylation
CAS NO: 737789-87-6 Product: Relugolix
Synonym: JNJ-17029259; JNJ 17029259; JNJ17029259.
IUPAC Chemical Name: 5-Pyrimidinecarbonitrile, 4-(4-(1-amino-1-methylethyl)phenyl)-2-((4-(2-(4-morpholinyl)ethyl)phenyl)amino)-
In ChiKey: Factor Xa inhibitors
SMILE Code: N#CC1=CN=C(NC2=CC=C(CCN3CCOCC3)C=C2)N=C1C4=CC=C(C(C)(N)C)C=C4
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Web Site click
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22128185
Chemical Formula：C26H30N6O
ExactMass: 442.24811
Molecular Weight: 442.56
Elemental Analysis: C, 70.56; H, 6.83; N, 18.99; O, 3.62
bet-bromodomain.com
BET Bromodomain Inhibitor
